December 17, 2014 / 12:36 PM / 3 years ago

BRIEF-Bayer submits application for FDA approval for BAY 81-8973

Dec 17 (Reuters) - Bayer Ag

* Says - submits application for u.s. Fda approval for recombinant factor VIII product (BAY 81-8973) for treatment of hemophilia a in adults and children

* Says submission follows bayer's recent application to european medicines agency (ema) for approval of same indication in european union

* Says plans to submit bay 81-8973 for approval in other countries in coming weeks and months Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below